Lee S K, Patel M V, Johnson M A. "一种的合成方法" [P]. US Patent, US 10505594 B2, 2016-06-27.
发明人朱建伟,刘建华,李文辉. "Method for the Synthesis of 162240-57-5
[(2S)-3-(1-ethoxycarbonyl-2-ethoxycarbonylsulfanylimidazol-4-yl)-1-methoxy-1-oxopropan-2-yl]-trimethylazanium;iodide" [P]. 中国发明专利, 专利号 CN 112629482 B, 授权公告日 2017-01-18.
发明人胡光,刘建华,杨光. "A Process for Preparing High-Purity 162240-57-5
[(2S)-3-(1-ethoxycarbonyl-2-ethoxycarbonylsulfanylimidazol-4-yl)-1-methoxy-1-oxopropan-2-yl]-trimethylazanium;iodide" [P]. 中国发明专利, 专利号 CN 114638403 B, 授权公告日 2016-09-14.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2025, 690, 8500-8528.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2014, 2041, (8), 7365-7382.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 162240-57-5
[(2S)-3-(1-ethoxycarbonyl-2-ethoxycarbonylsulfanylimidazol-4-yl)-1-methoxy-1-oxopropan-2-yl]-trimethylazanium;iodide Using HRMS and NMR". Chemosphere, 2011, 327, 1778-1800.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2025, 1391, (10), 6665-6672.